SLG
EXAS

Stanley-Laman Group’s Exact Sciences EXAS Stock Holding History

Stanley-Laman Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-93,550
Closed -$6.37M – 287
2024
Q3 		$6.37M Sell
93,550
-14,868
-14% -$839K 0.89% 19
2024
Q2 		$4.58M Sell
108,418
-10,272
-9% -$565K 0.66% 54
2024
Q1 		$8.2M Sell
118,690
-550
-0.5% -$34.8K 1.15% 14
2023
Q4 		$8.82M Buy
+119,240
New +$7.82M 1.35% 11
2021
Q4 		– Sell
-5,727
Closed -$547K – 273
2021
Q3 		$547K Buy
+5,727
New +$605K 0.07% 224

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Stanley-Laman Group's EXAS Position: Q4 2024 in Review

Stanley-Laman Group sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 93,550 shares — an estimated $6.37M sold.

Stanley-Laman Group first reported a position in EXAS in Q3 2021 and held it in 5 quarters. The position peaked at $8.82M in Q4 2023. 592 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Stanley-Laman Group reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • Stanley-Laman Group sold 93,550 Exact Sciences shares in Q4 2024, an estimated $6.37M.
  • Stanley-Laman Group first reported a position in Exact Sciences in Q3 2021 and held it in 5 quarters.
  • Stanley-Laman Group's Exact Sciences position peaked at $8.82M in Q4 2023.
  • 592 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Stanley-Laman Group's 13F filing for Q4 2024, filed 29 Jan 2025.